Which is cheaper: Mounjaro or Ozempic?

Direct answer for UK readers

There is no permanent winner on price. Total cost changes by dose, supply channel, consultation fees, and whether care is NHS, insured, or fully self-pay.

In the UK, these medicines are prescription-only and should be used through licensed pathways with clinician oversight. NHS eligibility, phased rollout, and local service capacity can affect access even when a medicine is legally available.

Sources: [2] [3] [4]

What UK guidance currently says

• NICE technology appraisals define who may be offered semaglutide or tirzepatide for obesity management.
• NHS England guidance describes phased implementation and wraparound care requirements.
• MHRA safety updates reinforce side-effect counseling and warnings about misuse or falsified products.
• Product leaflets confirm these medicines are prescription-only and require correct use.

Sources: [1] [2] [3] [5] [6] [7] [8]

Practical UK decision checklist

• Confirm whether your question is about obesity treatment, diabetes treatment, or both.
• Check local NHS access rules and whether specialist or primary-care pathways apply.
• Ask your clinician to review contraindications, interaction risks, and titration planning.
• Avoid non-regulated sellers and verify pharmacy legitimacy before paying privately.
• Document follow-up cadence, stop criteria, and long-term maintenance planning.

Sources: [3] [4] [5] [6]

Bottom line

UK legality does not mean universal access or universal suitability. The safest path is prescription-led care, clear eligibility checks, and structured follow-up rather than unverified online shortcuts.

If you are comparing products, focus on indication, risk profile, and support model before focusing on brand name alone.

Sources: [1] [2] [3] [5]